Courtney Dugan | Investor Relations |
Mitchell Gold | Chairman and Chief Executive Officer |
Stanford Peng | President and Head, Research and Development |
Paul Rickey | Chief Financial Officer |
Remy Durand | Senior Vice President, Business Development and Corporate Strategy |
Ted Tenthoff | Piper Jaffray |
Mark Breidenbach | Oppenheimer |
Wangzhi Li | Ladenburg |
Good afternoon, ladies and gentlemen and thank you for joining the Alpine Immune Sciences’ Fourth Quarter and Year End 2019 Company Update Conference Call. All participants are now in a listen-only mode.
Following opening remarks, Alpine’s management will open the lines for a question-and-answer period. Please be advised this call is being recorded at the company’s request and a webcast of this call will be archived on the company’s website for approximately two weeks. I would now like to introduce Courtney Dugan, Investor Relations.